Forthcoming complications in recovered COVID-19 patients with COPD and asthma; possible therapeutic opportunities.
Cell Commun Signal
; 20(1): 173, 2022 11 01.
Article
in English
| MEDLINE | ID: covidwho-2098351
ABSTRACT
Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been growing swiftly worldwide. Patients with background chronic pulmonary inflammations such as asthma or chronic obstructive pulmonary diseases (COPD) are likely to be infected with this virus. Of note, there is an argument that COVID-19 can remain with serious complications like fibrosis or other pathological changes in the pulmonary tissue of patients with chronic diseases. Along with conventional medications, regenerative medicine, and cell-based therapy could be alternative approaches to compensate for organ loss or restore injured sites using different stem cell types. Owing to unique differentiation capacity and paracrine activity, these cells can accelerate the healing procedure. In this review article, we have tried to scrutinize different reports related to the harmful effects of SARS-CoV-2 on patients with asthma and COPD, as well as the possible therapeutic effects of stem cells in the alleviation of post-COVID-19 complications. Video abstract.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Asthma
/
Pulmonary Disease, Chronic Obstructive
/
COVID-19
Topics:
Long Covid
Limits:
Humans
Language:
English
Journal:
Cell Commun Signal
Year:
2022
Document Type:
Article
Affiliation country:
S12964-022-00982-5
Similar
MEDLINE
...
LILACS
LIS